A pleiotropic SIS-based hydrogel with immunomodulation via NLRP3 inflammasome inhibition for diabetic bone regeneration
Chemical Engineering Journal · 2024-01 · 480 · 147985
DOI: 10.1016/j.cej.2023.147985 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Engineering Journal, 2024-01. Verfasst von Ning Sheng und 10 weiteren Autor:innen. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sheng, N., Xing, F., Zhang, Q., Tan, J., Nie, R., Huang, K., Li, H., Jiang, Y., Tan, B., Xiang, Z., & Xie, H. (2024). A pleiotropic SIS-based hydrogel with immunomodulation via NLRP3 inflammasome inhibition for diabetic bone regeneration. Chemical Engineering Journal, 480, 147985. https://doi.org/10.1016/j.cej.2023.147985
Vancouver
Sheng N, Xing F, Zhang Q, Tan J, Nie R, Huang K, et al. A pleiotropic SIS-based hydrogel with immunomodulation via NLRP3 inflammasome inhibition for diabetic bone regeneration. Chemical Engineering Journal. 2024;480:147985. doi:10.1016/j.cej.2023.147985
BibTeX
@article{Sheng2024,
author = {Sheng, Ning and Xing, Fei and Zhang, Qing-Yi and Tan, Jie and Nie, Rong and Huang, Kai and Li, He-Xi and Jiang, Yan-Lin and Tan, Bo and Xiang, Zhou and Xie, Hui-Qi},
title = {A pleiotropic SIS-based hydrogel with immunomodulation via NLRP3 inflammasome inhibition for diabetic bone regeneration},
journal = {Chemical Engineering Journal},
year = {2024},
volume = {480},
pages = {147985},
doi = {10.1016/j.cej.2023.147985}
}
EUVIMED